Cargando…

Assessment of the feed additives consisting of Lactiplantibacillus plantarum DSM 3676, Lactiplantibacillus plantarum DSM 3677 and Lentilactobacillus buchneri DSM 13573 for all animal species for the renewal of their authorisations (ADDCON GmbH)

Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the assessment of the application for renewal of three additives consisting of Lactiplantibacillus plantarum DSM 3676, Lactiplantibacillus plantarum DSM 3677 and Lentilactobacillus buchneri DSM 13573,...

Descripción completa

Detalles Bibliográficos
Autores principales: Bampidis, Vasileios, Azimonti, Giovanna, Bastos, Maria de Lourdes, Christensen, Henrik, Dusemund, Birgit, Durjava, Mojca, Kouba, Maryline, López‐Alonso, Marta, López Puente, Secundino, Marcon, Francesca, Mayo, Baltasar, Pechová, Alena, Petkova, Mariana, Ramos, Fernando, Sanz, Yolanda, Villa, Roberto Edoardo, Woutersen, Ruud, Freixa, Montserrat Anguita, Brozzi, Rosella, García‐Cazorla, Yolanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369231/
https://www.ncbi.nlm.nih.gov/pubmed/37502012
http://dx.doi.org/10.2903/j.efsa.2023.8162
Descripción
Sumario:Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the assessment of the application for renewal of three additives consisting of Lactiplantibacillus plantarum DSM 3676, Lactiplantibacillus plantarum DSM 3677 and Lentilactobacillus buchneri DSM 13573, respectively, as technological additives to improve ensiling of fresh material for all animal species. The applicant provided evidence that the additives currently on the market comply with the existing conditions of authorisation. There is no new evidence that would lead the FEEDAP Panel to reconsider its previous conclusions. Thus, the Panel concludes that the additives remain safe for all animal species, consumers and the environment under the authorised conditions of use. Regarding user safety, the additives are not irritant to skin or eyes, but owing to their proteinaceous nature they should be considered respiratory sensitisers. No conclusions can be drawn on the skin sensitisation potential of the additives. There is no need for assessing the efficacy of the additives in the context of the renewal of the authorisations.